Targeting P-glycoprotein for Effective Oral Anti-Cancer Chemotherapeutics

E-ISSN： 1873-5576|8|1|47-52

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.8, Iss.1, 2008-02, pp. : 47-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Phosphatidylserine in Anti-Cancer Therapy

Current Pharmaceutical Design, Vol. 15, Iss. 23, 2009-08 ,pp. : 2719-2723

Bentham Science Publishers

Access to resources Recommend Favorite

Synthetic Small Molecule Inhibitors of Hh Signaling As Anti-Cancer Chemotherapeutics

Current Medicinal Chemistry, Vol. 22, Iss. 35, 2015-11 ,pp. : 4033-4057

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice

By Bardelmeijer Heleen Ouwehand Mariët Beijnen Jos Schellens Jan van Tellingen Olaf

Investigational New Drugs, Vol. 22, Iss. 3, 2004-08 ,pp. : 219-229

Springer Publishing Company

Access to resources Recommend Favorite

P-glycoprotein as a Drug Target in the Treatment of Multidrug Resistant Cancer

Current Drug Targets, Vol. 1, Iss. 1, 2000-07 ,pp. : 85-99

Bentham Science Publishers

Access to resources Recommend Favorite

P-Glycoprotein - Implications of Metabolism of Neoplastic Cells and Cancer Therapy

Current Cancer Drug Targets, Vol. 5, Iss. 6, 2005-09 ,pp. : 457-468

Bentham Science Publishers

Access to resources Recommend Favorite